Outsourced Pharma Capacity Update Videos - Cell & Gene

1. Viralgen Capacity Update July 2025: Cell & Gene Therapy 7/28/2025

   As a leading CDMO in AAV manufacturing, Viralgen facilitates rapid transition to cGMP with a proven platform and an impeccable 100% IND success rate. Discover how Viralgen drives industry progress.

2. Minaris Advanced Therapies Capacity Update July 2025: Cell & Gene Therapy 7/28/2025

   With a robust track record of more than 7,500 GMP batches and proven platforms for multiple modalities, Minaris delivers speed, scalability, and reliability to help therapeutic developers bring cures to patients faster.

3. Excellos Capacity Update July 2025: Cell & Gene Therapy 7/28/2025

   Excellos leverages its extensive starting material expertise as a key differentiator. Explore how our deep understanding of partner-sourced raw materials, quality control, and supply chain management creates significant value for our clients.

4. Andelyn Biosciences Capacity Update July 2025: Cell & Gene Therapy 7/28/2025

   Andelyn Biosciences has used our Curator™ adherent platform to manufacture more than 450 Phase 1 and 2 clinical batches, spanning over 17 years and covering a variety of serotypes and indications.

5. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Director of Commercial Development, Serat Ali, describes FDBs' Advanced Therapy capabilities, discusses their global facilities network, and provides a capacity update.

6. Vinta Bio Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Uncover how an intensified adherent AAV manufacturing process is unlocking high-yield, low-impurity clinical production with over 95% full capsids in a streamlined, compact platform.

7. Kincell Bio Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Explore how expert CMC strategies and clinical manufacturing experience can lay the groundwork for the successful commercialization of advanced cell therapies.

8. Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   Witness how NYBCe and CCS are transforming cell and gene therapy development with end-to-end CDMO solutions, advanced logistics, and a growing innovation hub in Louisville.

9. Miltenyi Biotec B.V. & Co. KG Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

   In this presentation, Shaan Gareeb highlights the capabilities of our Cell Therapy Center of Excellence in San Jose, California, one of five global Miltenyi Bioindustry sites.

10. Optimization-By-Design: A Critical Factor In Viral Vector Scale Up, Scale Down 4/24/2025

    Focusing on critical parameters such as cell culture conditions, viral vector yield, and downstream purification strategies, can drive the success of scale-up and scale-down models for AAV production.